title: Epidemiology and mortality of adult burns in Catalonia.
abstract: Burn injuries still produce significant morbidity and mortality in developed countries. The incidence of burns in Catalonia is similar to other countries, with 31.2 per 100000 person/year referred to a specialized unit for definitive treatment. The Burn Center of the Vall d'Hebron hospital system is located at the General Hospital. It is the only facility for burns in the state of Catalonia. The catchment population is 6 million people, with 1814 +/- 89 burned patients treated in the emergency room per year and 396 +/- 15 of them admitted per year. Overall mortality is 3.49%. Inhalation injury and ARDS have a low incidence in our series with a high mortality. Factors associated with an increase in mortality are contact burns, inhalation injury, age and burn size. Pre-existing conditions did not affect survival in our series and 75% of all deaths occurred in the first week. Patients were treated with early serial debridement and cerium nitrate sulfadiazine, with results comparable to others in the literature. Mortality rates were compared to the Abbreviated Burn Severity Index, with a disparity in results, advocating the necessity to find a better and more applicable prognostic test for the outcome of burn injuries.
authors.affiliation: Plastic and Reconstructive Surgery and Burn Unit, Hospital General i Universitari Vall d'Hebron, Barcelona, Spain.
authors.forename: J P
authors.initials: JP
authors.lastname: Barret
authors.forename: P
authors.initials: P
authors.lastname: Gomez
authors.forename: I
authors.initials: I
authors.lastname: Solano
authors.forename: M
authors.initials: M
authors.lastname: Gonzalez-Dorrego
authors.forename: F J
authors.initials: FJ
authors.lastname: Crisol
mesh_terms: D015998:Abbreviated Injury Scale; D000328:Adult; D000367:Age Factors; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001830:Body Surface Area; D002056:Burns / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D002059:Burns, Inhalation / Q000453:epidemiology / Q000401:mortality; D002391:Catchment Area, Health / Q000706:statistics & numerical data; D002563:Cerium / Q000627:therapeutic use; D015897:Comorbidity; D003646:Debridement; D005260:Female; D006769:Hospitals, General / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010343:Patient Admission / Q000706:statistics & numerical data; D011379:Prognosis; D012128:Respiratory Distress Syndrome / Q000453:epidemiology / Q000401:mortality; D013030:Spain / Q000453:epidemiology; D013411:Sulfadiazine / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors
chemical_list: D000891:Anti-Infective Agents, Local; D013411:Sulfadiazine; C032786:cerium nitrate; D002563:Cerium